Morgan Stanley’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,492,887
Closed -$593M 6869
2018
Q4
$593M Sell
4,492,887
-147,128
-3% -$18.8M 0.18% 124
2018
Q3
$620M Buy
4,640,015
+74,170
+2% +$11.1M 0.16% 144
2018
Q2
$727M Buy
4,565,845
+25,304
+0.6% +$3.75M 0.2% 110
2018
Q1
$649M Sell
4,540,541
-174,363
-4% -$23.8M 0.18% 114
2017
Q4
$627M Buy
4,714,904
+15,107
+0.3% +$1.93M 0.17% 122
2017
Q3
$584M Buy
4,699,797
+301,627
+7% +$41.5M 0.18% 128
2017
Q2
$618M Sell
4,398,170
-116,135
-3% -$14.5M 0.19% 119
2017
Q1
$509M Buy
4,514,305
+397,837
+10% +$46.4M 0.16% 140
2016
Q4
$433M Buy
4,116,468
+533,740
+15% +$57.4M 0.14% 152
2016
Q3
$452M Buy
3,582,728
+108,646
+3% +$13.8M 0.15% 143
2016
Q2
$479M Sell
3,474,082
-352,714
-9% -$46.7M 0.17% 133
2016
Q1
$531M Sell
3,826,796
-101,201
-3% -$13.9M 0.2% 114
2015
Q4
$632M Buy
3,927,997
+131,022
+3% +$20.2M 0.23% 95
2015
Q3
$506M Sell
3,796,975
-204,780
-5% -$26.7M 0.19% 119
2015
Q2
$459M Sell
4,001,755
-540,672
-12% -$64.6M 0.16% 153
2015
Q1
$542M Sell
4,542,427
-330,705
-7% -$44.1M 0.2% 121
2014
Q4
$710M Sell
4,873,132
-199,416
-4% -$25M 0.26% 77
2014
Q3
$668M Sell
5,072,548
-7,528
-0.1% -$992K 0.26% 76
2014
Q2
$636M Buy
5,080,076
+315,135
+7% +$40.7M 0.25% 74
2014
Q1
$764M Buy
4,764,941
+88,922
+2% +$14.6M 0.32% 53
2013
Q4
$629M Sell
4,676,019
-407,781
-8% -$52.4M 0.27% 68
2013
Q3
$552M Sell
5,083,800
-205,155
-4% -$22.2M 0.26% 76
2013
Q2
$448M Buy
+5,288,955
New +$473M 0.23% 97

Morgan Stanley's ATHN Position: Q1 2019 in Review

Morgan Stanley sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 4,492,887 shares — an estimated $593M sold.

Morgan Stanley first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $764M in Q1 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Morgan Stanley reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Morgan Stanley sold 4,492,887 Athenahealth, Inc. shares in Q1 2019, an estimated $593M.
  • Morgan Stanley first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Morgan Stanley's Athenahealth, Inc. position peaked at $764M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Morgan Stanley's 13F filing for Q1 2019, filed 15 May 2019.